Dysregulation of FTO is observed in various cancers, including acute myeloid leukemia (AML), glioblastoma, cervical squamous cell carcinoma (CSCC), gastric cancer, and small cell lung cancer. The gene discussed is FTO; the disease is acute myeloid leukemia.